Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2367 (LINC02367) is a human gene encoding a long intergenic non-coding RNA (lincRNA)—a type of RNA transcript over 200 nucleotides in length that does not overlap with protein-coding genes and is not translated into protein. lincRNAs, as a class, are known to participate in diverse regulatory processes such as chromatin remodeling, transcriptional regulation, and fine-tuning gene expression with high tissue specificity. However, there is currently no specific functional, disease, or drug interaction data published for LINC02367 itself. LINC02367 is an annotated non-coding RNA gene, with entries in major databases such as GeneCards and BioGPS describing it as a long intergenic non-protein coding RNA without established protein product or well-defined direct biological roles. Long intergenic non-coding RNAs generally function in regulatory processes and sometimes in disease but only a minority of them have been characterized in detail. No evidence currently classifies LINC02367 as a receptor, enzyme, transporter, transcription factor, or other traditional therapeutic protein targets. It is unlikely to be a direct drug target based on current knowledge. No publications or databases in the provided results indicate known interacting drugs, mechanisms of action for drug targeting, biomarker status, or disease associations specific to LINC02367. There is no indication of incorrect nomenclature or data for this entry; the annotation matches established gene database conventions. This summary is based on authoritative gene and molecular biology databases and literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2367 (LINC02367).